Epigenetic therapy innovation creating infrastructure — histone deacetylase inhibitors modulating chromatin structure and gene expression enabling novel cancer and disease treatment, establishing HDAC inhibition as essential epigenetic therapy infrastructure, with the HDAC Inhibitor Market experiencing expansion driven by epigenetic disease understanding, precision medicine emphasis, and...